Livongo Health Inc LVGO shares are trading higher on Tuesday, after the company reported first-quarter sales guidance above prior forecasts.
The company sees preliminary first-quarter sales of $65.5-$66.5 million, up from $60-$62 million prior guidance.
Livongo Health provides an integrated suite of solutions for the healthcare industry in the U.S. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science.
Livongo Health shares were trading up 9.37% at $32.91 on Tuesday at time of publication. The stock has a 52-week high of $45.68 and a 52-week low of $15.12.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.